---
title: "Only Jinsan Biotechnology has completed a Pre-A+ round financing of tens of millions of yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249065866.md"
description: "36Kr learned that Tuoxin Pharmaceutical, a company listed on the Shenzhen Stock Exchange, announced a strategic investment of tens of millions of yuan in Jiangsu Jincan Biotechnology and signed a cooperation agreement. This comes just three months after Jiangsu Jincan completed its 100 million yuan Pre-A round of financing, demonstrating the capital market's continued optimism about the industrialization of anti-aging raw material ergotamine"
datetime: "2025-07-18T02:51:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249065866.md)
  - [en](https://longbridge.com/en/news/249065866.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249065866.md)
generator: "portal-rs"
---

# Only Jinsan Biotechnology has completed a Pre-A+ round financing of tens of millions of yuan

36Kr learned that Tuoxin Pharmaceutical, a company listed on the Shenzhen Stock Exchange, announced a strategic investment of tens of millions of yuan in Jiangsu Jinsan Biotechnology and signed a cooperation agreement. This comes just three months after Jiangsu Jinsan completed its 100 million yuan Pre-A round of financing, demonstrating the capital market's continued optimism towards the industrialization of anti-aging raw material ergot sulfur

### Related Stocks

- [301089.CN](https://longbridge.com/en/quote/301089.CN.md)

## Related News & Research

- [Top Economist Takes Aim at Kevin Warsh’s Fed: Is Trump’s New Chair an Independent ‘Hawky Hawk’ or a ‘MAGA Sock Puppet’?](https://longbridge.com/en/news/297519761.md)
- [Security Risk Advisors Launches SCALR AI as a Free SOC AI Platform for Security Teams](https://longbridge.com/en/news/297523531.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [Trump announces Medicaid drug pricing deals with 9 firms](https://longbridge.com/en/news/297557074.md)
- [The biggest "lobster" has been released: OpenClaw 2.0 aims to solve three major problems for agents.](https://longbridge.com/en/news/297578236.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**